| 36896583 | A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children. | Am J Epidemiol | 2023 |
| 34962990 | Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus. | J Infect Dis | 2022 |
| 35302243 | When Off-Label Prescribing Becomes Politicized: Do No Harm. | J Clin Pharmacol | 2022 |
| 32433313 | MD-PhD Program Graduates' Engagement in Research: Results of a National Study. | Acad Med | 2021 |
| 34399660 | The Current State of Efforts to Address Disparities, Racism and Cultural Humility in Medical Education. | Am J Bioeth | 2021 |
| 33945409 | Why Have Uniform Informed Consent Documents When the Research Volunteers Are So Diverse? | Am J Bioeth | 2021 |
| 32314235 | Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USA. | J Gastrointest Surg | 2020 |
| 31910135 | Improving Comparative Effectiveness Trials. | Am J Bioeth | 2020 |
| 33226999 | Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. | PLoS One | 2020 |
| 30676902 | Serious Ethical Violations by Physicians: What's the Solution? | Am J Bioeth | 2019 |
| 34054207 | "It's Almost Like Gay Sex Doesn't Exist:" Parent-Child Sex Communication According to Gay, Bisexual, and Queer Adolescent Sons. | J Adolesc Res | 2019 |
| 31544676 | Clinical Research Is a Team Sport. | Am J Bioeth | 2019 |
| 28993074 | Obtaining waivers of parental consent: A strategy endorsed by gay, bisexual, and queer adolescent males for health prevention research. | Nurs Outlook | 2018 |
| 30248073 | In Reply to Fochtmann. | Acad Med | 2018 |
| 28661734 | Opportunities Missed and Created by the New Common Rule. | Am J Bioeth | 2017 |
| 28464167 | Strategies for Addressing a Broader Definition of Conflicts of Interest. | JAMA | 2017 |
| 28767494 | The Daunting Career of the Physician-Investigator. | Acad Med | 2017 |
| 27031612 | Institutional Conflict of Interest and the Translational Pathway. | JAMA Ophthalmol | 2016 |
| 26350171 | Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. | J Bone Miner Res | 2016 |
| 27759931 | Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. | J Bone Miner Res | 2016 |
| 27584151 | Institutional Conflict of Interest-Reply. | JAMA Ophthalmol | 2016 |
| 27870083 | Being Right Isn't Always Enough: NFL Culture and Team Physicians' Conflict of Interest. | Hastings Cent Rep | 2016 |
| 27649827 | A Conceptual Model for the Translation of Bioethics Research and Scholarship. | Hastings Cent Rep | 2016 |
| 27301167 | Barriers to Change in the Informed Consent Process: A Systematic Literature Review. | IRB | 2016 |
| 26374677 | Use of altered informed consent in pragmatic clinical research. | Clin Trials | 2015 |
| 26322666 | HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds. | J Acquir Immune Defic Syndr | 2015 |
| 26479110 | A Knotty Problem of Intertwined Rights. | Am J Bioeth | 2015 |
| 23712442 | Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. | J Bone Miner Res | 2014 |
| 25266426 | Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation. | Pediatrics | 2014 |
| 25055811 | Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation. | Clin Trials | 2014 |
| 23665997 | Systematic review and metasummary of attitudes toward research in emergency medical conditions. | J Med Ethics | 2014 |
| 23738513 | The OHRP and SUPPORT. | N Engl J Med | 2013 |
| 24256526 | Let the punishment fit the crime: sensible consent in the management of human subjects research and standard-of-care interventions. | Am J Bioeth | 2013 |
| 24024796 | Sports medicine and ethics. | Am J Bioeth | 2013 |
| 23741065 | Is conflict of interest becoming a challenge for institution-based institutional review boards? | Clin Cancer Res | 2013 |
| 22180560 | Developmental pharmacokinetic changes of Lamivudine in infants and children. | J Clin Pharmacol | 2012 |
| 23188024 | Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiative. | JAMA | 2012 |
| 22836222 | Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. | J Bone Miner Res | 2012 |
| 21288774 | First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. | Lancet Infect Dis | 2011 |
| 20386428 | Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children. | AIDS | 2010 |
| 20842676 | Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. | J Bone Miner Res | 2010 |
| 19543114 | Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus. | J Pediatr Gastroenterol Nutr | 2009 |
| 18981766 | Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. | AIDS | 2008 |
| 17646352 | Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. | Pediatrics | 2007 |
| 15696219 | Should an institution that has commercial rights in a new drug or device be allowed to evaluate the technology? | PLoS Med | 2005 |
| 15076247 | Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States. | J Acquir Immune Defic Syndr | 2004 |
| 15355940 | Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials. | J Antimicrob Chemother | 2004 |
| 15006193 | Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings. | AIDS Patient Care STDS | 2004 |
| 14743040 | Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. | Pediatr Infect Dis J | 2004 |
| 14758118 | Newer treatments for HIV in children. | Curr Opin Pediatr | 2004 |